Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeannina A Smith

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
JAMA|January 9, 2025
Invisible MeJeannina A Smith
Current Infectious Disease Reports|October 28, 2009
What is the role of therapeutic drug monitoring in antifungal therapy?Jeannina A Smith
Proceedings of the American Thoracic Society|May 14, 2010
BlastomycosisJeannina A Smith, Carol A Kauffman
Seminars in Respiratory and Critical Care Medicine|September 24, 2015
New Developments in BlastomycosisJeannina A Smith, Greg Gauthier
Critical Care Medicine|July 22, 2010
Recognition and prevention of nosocomial invasive fungal infections in the intensive care unitJeannina A Smith, Carol A Kauffman
Respirology (Carlton, Vic.)|February 17, 2012
Pulmonary fungal infectionsJeannina A Smith, Carol A Kauffman
Drugs|July 29, 2009
Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapyJeannina A Smith, Carol A Kauffman
Current Infectious Disease Reports|August 7, 2013
Cutaneous manifestations of endemic mycosesJeannina A Smith, James Riddell, Carol A Kauffman
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 18, 2022
Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19: A case seriesHanna L Kleiboeker, Margaret R Jorgenson, Jeannina A Smith
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 27, 2022
Belatacept may result in profound and persistent loss of cytomegalovirus-specific cell-mediated immunity: A case reportHanna L Kleiboeker, Margaret R Jorgenson, Jeannina A Smith
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
JAMA|January 9, 2025
Invisible MeJeannina A Smith
Current Infectious Disease Reports|October 28, 2009
What is the role of therapeutic drug monitoring in antifungal therapy?Jeannina A Smith
Proceedings of the American Thoracic Society|May 14, 2010
BlastomycosisJeannina A Smith, Carol A Kauffman
Seminars in Respiratory and Critical Care Medicine|September 24, 2015
New Developments in BlastomycosisJeannina A Smith, Greg Gauthier
Critical Care Medicine|July 22, 2010
Recognition and prevention of nosocomial invasive fungal infections in the intensive care unitJeannina A Smith, Carol A Kauffman
Respirology (Carlton, Vic.)|February 17, 2012
Pulmonary fungal infectionsJeannina A Smith, Carol A Kauffman
Drugs|July 29, 2009
Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapyJeannina A Smith, Carol A Kauffman
Current Infectious Disease Reports|August 7, 2013
Cutaneous manifestations of endemic mycosesJeannina A Smith, James Riddell, Carol A Kauffman
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 18, 2022
Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19: A case seriesHanna L Kleiboeker, Margaret R Jorgenson, Jeannina A Smith
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 27, 2022
Belatacept may result in profound and persistent loss of cytomegalovirus-specific cell-mediated immunity: A case reportHanna L Kleiboeker, Margaret R Jorgenson, Jeannina A Smith
Pageof 6